{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:14:31Z","timestamp":1767143671765,"version":"build-2238731810"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Amgen, Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1007\/s13555-023-00967-3","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T06:02:00Z","timestamp":1688191320000},"page":"1973-1984","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Apremilast Adherence and Persistence in Patients with Psoriasis and Psoriatic Arthritis in the Telehealth Setting Versus the In-person Setting During the COVID-19 Pandemic"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7110-9463","authenticated-orcid":false,"given":"Ashis K.","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0177-6153","authenticated-orcid":false,"given":"Eunice","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1636-5947","authenticated-orcid":false,"given":"Caleb","family":"Paydar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2049-5536","authenticated-orcid":false,"given":"Michael S.","family":"Broder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate K.","family":"Orroth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Myriam","family":"Cordey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,1]]},"reference":[{"issue":"Suppl 2","key":"967_CR1","first-page":"ii18","volume":"64","author":"RGB Langley","year":"2005","unstructured":"Langley RGB, Krueger GG, Griffiths CEM. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis. 2005;64(Suppl 2):ii18\u201323.","journal-title":"Ann Rheum Dis"},{"issue":"Suppl 2","key":"967_CR2","first-page":"ii14","volume":"64","author":"DD Gladman","year":"2005","unstructured":"Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64(Suppl 2):ii14\u20137.","journal-title":"Ann Rheum Dis"},{"issue":"17","key":"967_CR3","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.2165\/00003495-200262170-00004","volume":"62","author":"J Brockbank","year":"2002","unstructured":"Brockbank J, Gladman D. Diagnosis and management of psoriatic arthritis. Drugs. 2002;62(17):2447\u201357.","journal-title":"Drugs"},{"issue":"2","key":"967_CR4","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1080\/13696998.2018.1557201","volume":"22","author":"D Pilon","year":"2019","unstructured":"Pilon D, Teeple A, Zhdanava M, et al. The economic burden of psoriasis with high comorbidity among privately insured patients in the United States. J Med Econ. 2019;22(2):196\u2013203.","journal-title":"J Med Econ"},{"issue":"6","key":"967_CR5","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.jaad.2015.02.1099","volume":"72","author":"J Vanderpuye-Orgle","year":"2015","unstructured":"Vanderpuye-Orgle J, Zhao Y, Lu J, et al. Evaluating the economic burden of psoriasis in the United States. J Am Acad Dermatol. 2015;72(6):961-967.e5.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"967_CR6","first-page":"997","volume":"28","author":"A Ogdie","year":"2022","unstructured":"Ogdie A, Hwang M, Veeranki P, et al. Health care utilization and costs associated with functional status in patients with psoriatic arthritis. J Manag Care Spec Pharm. 2022;28(9):997\u20131007.","journal-title":"J Manag Care Spec Pharm"},{"issue":"11","key":"967_CR7","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1111\/ijd.13956","volume":"57","author":"TJ Stewart","year":"2018","unstructured":"Stewart TJ, Tong W, Whitfeld MJ. The associations between psychological stress and psoriasis: a systematic review. Int J Dermatol. 2018;57(11):1275\u201382.","journal-title":"Int J Dermatol"},{"issue":"6","key":"967_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2165\/00128071-200506060-00005","volume":"6","author":"AB Kimball","year":"2005","unstructured":"Kimball AB, Jacobson C, Weiss S, Vreeland MG, Wu Y. The psychosocial burden of psoriasis. Am J Clin Dermatol. 2005;6(6):383\u201392.","journal-title":"Am J Clin Dermatol"},{"issue":"12","key":"967_CR9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052935","volume":"7","author":"AW Armstrong","year":"2012","unstructured":"Armstrong AW, Schupp C, Wu J, Bebo B. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003\u20132011. PLoS\u00a0One. 2012;7(12):e52935.","journal-title":"PLoS\u00a0One"},{"issue":"2","key":"967_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3899\/jrheum.160180","volume":"44","author":"T Gudu","year":"2017","unstructured":"Gudu T, Kiltz U, de Wit M, Kvien TK, Gossec L. Mapping the effect of psoriatic arthritis using the international classification of functioning, disability and health. J Rheumatol. 2017;44(2):193\u2013200.","journal-title":"J Rheumatol"},{"issue":"5","key":"967_CR11","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1002\/acr.22492","volume":"67","author":"SR Feldman","year":"2015","unstructured":"Feldman SR, Zhao Y, Shi L, Tran MH, Lu J. Economic and comorbidity burden among moderate-to-severe psoriasis patients with comorbid psoriatic arthritis. Arthritis Care Res (Hoboken). 2015;67(5):708\u201317.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"967_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/art.40726","volume":"71","author":"JA Singh","year":"2019","unstructured":"Singh JA, Guyatt G, Ogdie A, et al. 2018 American College of Rheumatology\/National Psoriasis Foundation Guideline for the treatment of psoriatic arthritis. Arthritis Rheumatol. 2019;71(1):5\u201332.","journal-title":"Arthritis Rheumatol"},{"key":"967_CR13","unstructured":"American Academy of Dermatology Association. Psoriasis clinical guideline. 2023. https:\/\/www.aad.org\/member\/clinical-quality\/guidelines\/psoriasis. Accessed 6 Dec 2022."},{"issue":"Supplement_1","key":"967_CR14","doi-asserted-by":"publisher","first-page":"i37","DOI":"10.1093\/rheumatology\/kez383","volume":"59","author":"A Ogdie","year":"2020","unstructured":"Ogdie A, Coates LC, Gladman DD. Treatment guidelines in psoriatic arthritis. Rheumatology. 2020;59(Supplement_1):i37\u201346.","journal-title":"Rheumatology"},{"issue":"9","key":"967_CR15","first-page":"504","volume":"9","author":"SR Feldman","year":"2016","unstructured":"Feldman SR, Goffe B, Rice G, et al. The challenge of managing psoriasis: unmet medical needs and stakeholder perspectives. Am Health Drug Benefits. 2016;9(9):504\u201313.","journal-title":"Am Health Drug Benefits"},{"issue":"5","key":"967_CR16","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","volume":"58","author":"A Menter","year":"2008","unstructured":"Menter A, Gottlieb A, Feldman SR, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58(5):826\u201350.","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"967_CR17","doi-asserted-by":"publisher","first-page":"2955","DOI":"10.1038\/jid.2015.296","volume":"135","author":"J Takeshita","year":"2015","unstructured":"Takeshita J, Gelfand JM, Li P, et al. Psoriasis in the US medicare population: prevalence, treatment, and factors associated with biologic use. J Invest Dermatol. 2015;135(12):2955\u201363.","journal-title":"J Invest Dermatol"},{"issue":"10","key":"967_CR18","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1080\/03007995.2019.1618805","volume":"35","author":"S Higa","year":"2019","unstructured":"Higa S, Devine B, Patel V, Baradaran S, Wang D, Bansal A. Psoriasis treatment patterns: a retrospective claims study. Curr Med Res Opin. 2019;35(10):1727\u201333.","journal-title":"Curr Med Res Opin"},{"issue":"8","key":"967_CR19","first-page":"408","volume":"11","author":"Y Xu","year":"2018","unstructured":"Xu Y, Sudharshan L, Hsu M-A, et al. Patient preferences associated with therapies for psoriatic arthritis: a conjoint analysis. Am Health Drug Benefits. 2018;11(8):408\u201317.","journal-title":"Am Health Drug Benefits"},{"issue":"4","key":"967_CR20","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/ppul.24623","volume":"55","author":"NY Lin","year":"2020","unstructured":"Lin NY, Ramsey RR, Miller JL, et al. Telehealth delivery of adherence and medication management system improves outcomes in inner-city children with asthma. Pediatr Pulmonol. 2020;55(4):858\u201365.","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"967_CR21","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1089\/tmj.2011.0025","volume":"17","author":"R Parikh","year":"2011","unstructured":"Parikh R, TouVelle MN, Wang H, Zallek SN. Sleep telemedicine: patient satisfaction and treatment adherence. Telemed e-Health. 2011;17(8):609\u201314.","journal-title":"Telemed e-Health"},{"issue":"3","key":"967_CR22","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1176\/appi.ps.201800286","volume":"70","author":"LN Schulze","year":"2019","unstructured":"Schulze LN, Stentzel U, Leipert J, et al. Improving medication adherence with telemedicine for adults with severe mental illness. Psychiatr Serv. 2019;70(3):225\u20138.","journal-title":"Psychiatr Serv"},{"issue":"1","key":"967_CR23","doi-asserted-by":"publisher","DOI":"10.2196\/18901","volume":"23","author":"BPH Pouls","year":"2021","unstructured":"Pouls BPH, Vriezekolk JE, Bekker CL, et al. Effect of interactive ehealth interventions on improving medication adherence in adults with long-term medication: systematic review. J Med Internet Res. 2021;23(1):e18901.","journal-title":"J Med Internet Res"},{"key":"967_CR24","unstructured":"Headley M. Managing medication adherence during COVID-19. Patient Safety Quality Healthcare. 2020. https:\/\/www.psqh.com\/analysis\/managing-medication-adherence-during-covid-19\/. Accessed 25 Nov 2022."},{"issue":"1","key":"967_CR25","first-page":"30","volume":"43","author":"J Kim","year":"2018","unstructured":"Kim J, Combs K, Downs J, Tillman F III. Medication adherence: the elephant in the room. US Pharm. 2018;43(1):30\u20134.","journal-title":"US Pharm"},{"issue":"6","key":"967_CR26","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/jamia\/ocaa067","volume":"27","author":"J Wosik","year":"2020","unstructured":"Wosik J, Fudim M, Cameron B, et al. Telehealth transformation: COVID-19 and the rise of virtual care. J Am Med Inform Assoc. 2020;27(6):957\u201362.","journal-title":"J Am Med Inform Assoc"},{"issue":"12","key":"967_CR27","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1080\/17474124.2020.1822734","volume":"14","author":"C Efe","year":"2020","unstructured":"Efe C, Sim\u015fek C, Bat\u0131bay E, Cal\u0131\u015fkan AR, Wahlin S. Feasibility of telehealth in the management of autoimmune hepatitis before and during the COVID-19 pandemic. Expert Rev Gastroenterol Hepatol. 2020;14(12):1215\u20139.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"1","key":"967_CR28","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1186\/s12879-022-07787-4","volume":"22","author":"CK Lippincott","year":"2022","unstructured":"Lippincott CK, Perry A, Munk E, Maltas G, Shah M. Tuberculosis treatment adherence in the era of COVID-19. BMC Infect Dis. 2022;22(1):800.","journal-title":"BMC Infect Dis"},{"key":"967_CR29","doi-asserted-by":"publisher","unstructured":"Heidbrede T, Mevius A, Kessel S, Wilke T, Maywald U, Thiem A. Real-world systemic treatment of patients with psoriasis: a retrospective study based on German claims data. J Deutsche Dermatol Gesell. 2023;21(6):611-9. https:\/\/doi.org\/10.1111\/ddg.15030.","DOI":"10.1111\/ddg.15030"},{"issue":"4","key":"967_CR30","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jaad.2021.09.019","volume":"86","author":"JF Merola","year":"2022","unstructured":"Merola JF, Tian H, Patil D, et al. Incidence and prevalence of psoriatic arthritis in patients with psoriasis stratified by psoriasis disease severity: retrospective analysis of an electronic health records database in the United States. J Am Acad Dermatol. 2022;86(4):748\u201357.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"967_CR31","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1080\/13696998.2019.1571500","volume":"22","author":"JJ Wu","year":"2019","unstructured":"Wu JJ, Pelletier C, Ung B, Tian M. Real-world treatment patterns and healthcare costs among biologic-naive patients initiating apremilast or biologics for the treatment of psoriasis. J Med Econ. 2019;22(4):365\u201371.","journal-title":"J Med Econ"},{"issue":"1","key":"967_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1080\/03007995.2019.1668204","volume":"36","author":"JJ Wu","year":"2020","unstructured":"Wu JJ, Pelletier C, Ung B, Tian M. Treatment patterns and healthcare costs among biologic-naive patients initiating apremilast or biologics for the treatment of psoriatic arthritis: results from a US claims analysis. Curr Med Res Opin. 2020;36(1):169\u201376.","journal-title":"Curr Med Res Opin"},{"key":"967_CR33","unstructured":"Nau D. Proportion of Days Covered (PDC) as a Preferred Method of Measuring Medication Adherence. Pharmacy Quality Alliance, Springfield. http:\/\/www.pqaaliance.org\/files\/PDCvsMPRfinal.pdf. Accessed 3 Jan 2023."},{"key":"967_CR34","doi-asserted-by":"crossref","unstructured":"Chaudri NA. Adherence to long-term therapies evidence for action. Ann Saudi Med. 2004;24(3):221\u20132.","DOI":"10.5144\/0256-4947.2004.221"},{"key":"967_CR35","unstructured":"Optum, Inc. Medication adherence: Rx for success. 2012. https:\/\/www.optum.com\/content\/dam\/optum3\/optum\/en\/resources\/white-papers\/MedicationAdherence_WhitePaper.pdf. Accessed 1 Feb 2023."},{"key":"967_CR36","unstructured":"Ibis World. Telehealth services in the US\u2014market Ssze 2005\u20132029. 2023. https:\/\/www.ibisworld.com\/industry-statistics\/market-size\/telehealth-services-united-states\/. Accessed 1 Feb 2023."},{"key":"967_CR37","unstructured":"Grand View Research. Telehealth market size, share & trends analysis report by product type (software, services), by delivery mode (cloud-based, web-based), by end-use (payers, patients), by disease area, by region, and segment forecasts, 2023-2030. https:\/\/www.grandviewresearch.com\/industry-analysis\/telehealth-market-report. Accessed 1 Feb 2023."},{"key":"967_CR38","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.220658","author":"TSH Kwok","year":"2022","unstructured":"Kwok TSH, Kuriya B, King LK, et al. Changes in service delivery and access to rheumatologists before and during the COVID-19 pandemic in a Canadian universal healthcare setting. J Rheumatol. 2022. https:\/\/doi.org\/10.3899\/jrheum.220658.","journal-title":"J Rheumatol"},{"issue":"22","key":"967_CR39","doi-asserted-by":"publisher","first-page":"14682","DOI":"10.3390\/ijerph192214682","volume":"19","author":"MA Vicente","year":"2022","unstructured":"Vicente MA, Fern\u00e1ndez C, Guilabert M, et al. Patient engagement using telemedicine in primary care during COVID-19 pandemic: a trial study. Int J Environ Res Public Health. 2022;19(22):14682.","journal-title":"Int J Environ Res Public Health"},{"key":"967_CR40","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.2147\/PPA.S373309","volume":"16","author":"AM Edwards","year":"2022","unstructured":"Edwards AM, Petitt JC, Kumar S, Levin JB, Sajatovic M. Pre COVID-19 pandemic use of telemedicine for adherence promotion in patients with psychotic disorders: a literature review. Patient Prefer Adherence. 2022;16:2559\u201365.","journal-title":"Patient Prefer Adherence"},{"key":"967_CR41","doi-asserted-by":"publisher","DOI":"10.1177\/08971900221136629","author":"BE Bruns","year":"2022","unstructured":"Bruns BE, Lorenzo-Castro SA, Hale GM. Controlling blood pressure during a pandemic: the impact of telepharmacy for primary care patients. J Pharm Pract. 2022. https:\/\/doi.org\/10.1177\/08971900221136629.","journal-title":"J Pharm Pract"},{"issue":"5","key":"967_CR42","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/jcag\/gwac016","volume":"5","author":"HJ Kim","year":"2022","unstructured":"Kim HJ, Tomaszewski M, Zhao B, et al. Impact of telehealth on medication adherence in chronic gastrointestinal diseases. J Can Assoc Gastroenterol. 2022;5(5):203\u20137.","journal-title":"J Can Assoc Gastroenterol"},{"issue":"6","key":"967_CR43","first-page":"1569","volume":"10","author":"PJ Cvietusa","year":"2022","unstructured":"Cvietusa PJ, Goodrich GK, Steiner JF, et al. Transition to virtual asthma care during the COVID-19 pandemic: an observational study. J Allergy Clin Immunol. 2022;10(6):1569\u201376.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"967_CR44","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.japh.2021.09.011","volume":"62","author":"AG Woodhouse","year":"2022","unstructured":"Woodhouse AG, Orvin C, Rich C, Crosby J, Keedy CA. Diabetes outcomes before and during telehealth advancements surrounding COVID-19. J Am Pharm Assoc. 2022;62(1):214\u20137.","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"967_CR45","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1111\/j.1365-2133.2012.11205.x","volume":"168","author":"N Balato","year":"2013","unstructured":"Balato N, Megna M, Di Costanzo L, Balato A, Ayala F. Educational and motivational support service: a pilot study for mobile-phone-based interventions in patients with psoriasis: telepsoriasis services. Br J Dermatol. 2013;168(1):201\u20135.","journal-title":"Br J Dermatol"},{"issue":"6","key":"967_CR46","doi-asserted-by":"publisher","first-page":"680","DOI":"10.2340\/00015555-1148","volume":"91","author":"S Koller","year":"2011","unstructured":"Koller S, Hofmann-Wellenhof R, Hayn D, et al. Teledermatological monitoring of psoriasis patients on biologic therapy. Acta Derm Venerol. 2011;91(6):680\u20135.","journal-title":"Acta Derm Venerol"},{"issue":"6","key":"967_CR47","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.3062","volume":"1","author":"AW Armstrong","year":"2018","unstructured":"Armstrong AW, Chambers CJ, Maverakis E, et al. Effectiveness of online vs. in-person care for adults with psoriasis: a randomized clinical trial. JAMA Netw Open. 2018;1(6): e183062.","journal-title":"JAMA Netw Open"},{"issue":"7","key":"967_CR48","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00296-021-04863-x","volume":"41","author":"M Chevallard","year":"2021","unstructured":"Chevallard M, Belloli L, Ughi N, et al. Use of telemedicine during the COVID-19 pandemic in patients with inflammatory arthritis: a retrospective study on feasibility and impact on patient-reported outcomes in a real-life setting. Rheumatol Int. 2021;41(7):1253\u201361.","journal-title":"Rheumatol Int"},{"issue":"4","key":"967_CR49","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s13555-021-00555-3","volume":"11","author":"P Gisondi","year":"2021","unstructured":"Gisondi P, Bellinato F, Piaserico S, Di Leo S, Cazzaniga S, Naldi L. Preference for telemedicine vs. in-person visit among patients with psoriasis receiving biological drugs. Dermatol Ther (Heidelb). 2021;11(4):1333\u201343.","journal-title":"Dermatol Ther (Heidelb)"},{"issue":"12","key":"967_CR50","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.1007\/s10067-021-05759-8","volume":"40","author":"SS Kong","year":"2021","unstructured":"Kong SS, Otalora Rojas LA, Ashour A, Robinson M, Hosterman T, Bhanusali N. Ability and willingness to utilize telemedicine among rheumatology patients\u2014a cross-sectional survey. Clin Rheumatol. 2021;40(12):5087\u201393.","journal-title":"Clin Rheumatol"},{"key":"967_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152045","volume":"56","author":"LE Jackson","year":"2022","unstructured":"Jackson LE, Edgil TA, Hill B, et al. Telemedicine in rheumatology care: a systematic review. Semin Arthritis Rheum. 2022;56: 152045.","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"967_CR52","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.36405","volume":"4","author":"ZS Predmore","year":"2021","unstructured":"Predmore ZS, Roth E, Breslau J, Fischer SH, Uscher-Pines L. Assessment of patient preferences for telehealth in post\u2013COVID-19 pandemic health care. JAMA Netw Open. 2021;4(12): e2136405.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"967_CR53","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jvc2.93","volume":"2","author":"MHM El Komy","year":"2023","unstructured":"El Komy MHM, Chiricozzi A, van de Kerkhof P, et al. Telemedicine and psoriasis: a review based on statements of the telemedicine working group of the international psoriasis council. JEADV Clin Practice. 2023;2(1):19\u201331.","journal-title":"JEADV Clin Practice"}],"updated-by":[{"DOI":"10.1007\/s13555-023-00984-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,7,23]],"date-time":"2023-07-23T00:00:00Z","timestamp":1690070400000}}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-00967-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-023-00967-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-023-00967-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T15:06:13Z","timestamp":1692630373000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-023-00967-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["967"],"URL":"https:\/\/doi.org\/10.1007\/s13555-023-00967-3","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,1]]},"assertion":[{"value":"9 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s13555-023-00984-2","URL":"https:\/\/doi.org\/10.1007\/s13555-023-00984-2","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}